510(k) Report

510(k) · Cleared

Cleared

Lyphochek Whole Blood Immunosuppressant Control , Abbott Immunosuppressant MCC

K072721510(k) TraditionalCleared Dec 11, 200776-day reviewClass I21 CFR 862.3280

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad, Diagnostics Grp. · DIF Drug Mixture Control Materials

Cleared on Dec 11, 2007 as substantially equivalent to K022041 (Bio-Rad Laboratories, Inc., 2002) after a 76-day review. Its family tree reaches back 3 generations to 1990. 2 later devices descend from it.

Decided
Dec 11, 2007
Review
76 days
Class
Class I
Product code
DIF
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K895905 (1990). 2 later devices descend from it, 2 citing it directly.

  1. Root · 3 generations backK895905 Lyphochek Whole Blood Control (Human) Levels 1,2,3Bio-Rad · 1990
  2. 2 generations backK980871 Lyphochek Whole Blood ControlBio-Rad · 1998
  3. 1 generation backK022041 Lyphochek Whole Blood Control, Models 561, 562, 563Bio-Rad Laboratories, Inc. · 2002
  4. This deviceK072721 Lyphochek Whole Blood Immunosuppressant Control , Abbott…Bio-Rad, Diagnostics Grp. · 2007
  5. Descendant · cites it directly · 0 of its ownK132174 Multichem WBTTechno-Path Manufacturing, Ltd. · 2013
  6. Descendant · cites it directly · 0 of its ownK080459 Chromesytems Toxicology Calibrators and ControlsChromsystems Instruments & Chemicals GmbH · 2009

Most influential descendants

Showing 2 of 2 · See all
  • K132174Multichem WBTTechno-Path Manufacturing, Ltd. · 2013 · cites it directly0descendants
  • K080459Chromesytems Toxicology Calibrators and ControlsChromsystems Instruments & Chemicals GmbH · 2009 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K895905Lyphochek Whole Blood Control (Human) Levels 1,2,3Bio-Rad1990—
−2K980871Lyphochek Whole Blood ControlBio-Rad1998—
−1K022041Lyphochek Whole Blood Control, Models 561, 562, 563Bio-Rad Laboratories, Inc.2002—
0 (this device)K072721Lyphochek Whole Blood Immunosuppressant Control , Abbott Immunosuppressant MCCBio-Rad, Diagnostics Grp.2007—
+1K132174Multichem WBTTechno-Path Manufacturing, Ltd.2013—
+1K080459Chromesytems Toxicology Calibrators and ControlsChromsystems Instruments & Chemicals GmbH2009—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
201310
FIG. 1 — Lineage of K072721, 1990–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DIF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K022041Lyphochek Whole Blood Control, Models 561, 562, 563
Summary page 1
…stantial Equivalence is Claimed Lyphochek Whole Blood Control Bio-Rad Laboratories Irvine, California 92618 510 (k) Number: K022041 4.0 Description of Device Lyphochek Whole Blood Immunosuppressant Controls and Abbott Immunosuppressant…
Bio-Rad Laboratories, Inc.2002—

Also cleared against K022041: 3 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K132174Multichem WBTTechno-Path Manufacturing, Ltd.20130
K080459Chromesytems Toxicology Calibrators and ControlsChromsystems Instruments & Chemicals GmbH20090

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 3 companies; a new generation was cleared every 5.4 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K132174 (Techno-Path Manufacturing, Ltd., 2013) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K022041.

How does its category compare?

All DIF devices

DIF Drug Mixture Control Materials: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · DIF

1in 2016

2007: 12008: 22010: 12011: 12012: 32013: 22016: 1
2007high 3 (2012) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DIF

35in 2012

2012: 35 days median
2007high 35 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DIF

1in 2021

2011: 12013: 12017: 52021: 1
2007high 5 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DIF

1in 2016

2011: 12012: 32016: 1
2007high 3 (2012) · low 0 (2007)2025

MAUDE reports naming product code DIF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—00
20090—00
20101—00
20111—11
201233503
20132—10
20140—00
20150—00
20161—01
20170—50
20180—00
20190—00
20200—00
20210—10
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

Lyphochek Whole Blood Immunosuppressant Controls is intended for use as an assayed quality control material to monitor the precision of laboratory testing procedures for the analytes listed in the package insert.

The following analytes are listed in the package insert:

Sirolimus

Tacrolimus

Cyclosporine

Abbott Immunosuppressant MCC is intended for use as an assayed quality control material to monitor the precision of laboratory testing procedures for the analytes listed in the package insert.

The following analytes are listed in the package insert:

Sirolimus

Tacrolimus

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K072721: Lyphochek Whole Blood Immunosuppressant Control , Abbott Immunosuppressant MCC.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K072721

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026